Panel Discussion: How can biotechs best leverage partnerships early on in drug development to ensure cancer vaccine success?
Time: 11:45 am
day: Day Two
Details:
- Assessing the importance of bringing in the right staff from the field
- Developing the science and the story in early development to attract potential
partners, when you don’t have clinical data available - Attributes of a perfect partnership
- Types of partnerships (in/out licensing of product, financing of clinical trial,
providing comparator drug, etc.) - Key partnerships crucial at different timepoints
- Evidence from the field where effective partnerships have resulted in key
developments
